Podcast Music Movie Game Book
  1. 🎧Podcast
  2. 🎧U.S. Food and Drug Administration, Center for Drug Evaluation and Research
  3. FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma

FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma

Release Date:

FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma
FDA medical oncologists discuss the January 14, 2019, approval of cabozantinib for patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib.

FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma
Title
FDA D.I.S.C.O.: FDA approval of cabozantinib for hepatocellular carcinoma
Copyright
Release Date

flashback